Vivoo is a wellness-tech company founded in 2017 with the slogan "Pee-testing wellness tracker." The company offers personalized wellness products using advanced technology. Vivoo's flagship product is an at-home urine test and mobile application that provides real-time body data on various metrics such as Vitamin C, Magnesium, Calcium, Water, Ketone, Sodium, pH, Oxidative Stress, and Protein. Users can receive personalized nutritional and lifestyle advice, order customized supplements, and access over 300 wellness articles through the app. Additionally, Vivoo integrates wearable data to provide insights into activity, sleep, and heart rate. The company's mission is to democratize access to body data and enhance understanding for consumers worldwide, ultimately empowering them to lead healthier lives. Vivoo has secured a $10.00M Series B investment from prominent investors including Halogen Ventures, Draper Associates, Caucasus Ventures, Mindshift Capital, Otsuka Holdings, and Istanbul Technical University. This investment reflects the confidence of industry leaders in Vivoo's innovative approach and underscores its potential for future success in the AI, Health Care, Health and Wellness, and Machine Learning sectors.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $10.00M | 6 | Otsuka Holdings, Istanbul Technical University | 15 Jul 2024 |
Series A | $6.32M | 4 | Tim Draper | 25 Jun 2021 |
Seed Round | $1.50M | 1 | 14 Jan 2020 | |
Pre Seed Round | $465.00K | 5 | Zeynep Zorlu, Bayer Pharmaceuticals | 12 Jan 2019 |
Pre Seed Round | $120.00K | 3 | SkyDeck Berkeley, 500 Global | 01 Jan 2018 |
Big Bang Londra Demo Day için seçilen 25 girişim